Cargando…
Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy
OBJECTIVE—Hyperglycemia is a risk factor for microvascular complications and may increase the risk of cardiovascular disease in patients with type 2 diabetes. This study tested the LDL cholesterol–lowering agent colesevelam HCl (colesevelam) as a potential novel treatment for improving glycemic cont...
Autores principales: | Fonseca, Vivian A., Rosenstock, Julio, Wang, Antonia C., Truitt, Kenneth E., Jones, Michael R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494667/ https://www.ncbi.nlm.nih.gov/pubmed/18458145 http://dx.doi.org/10.2337/dc08-0283 |
Ejemplares similares
-
Safety and Efficacy of Colesevelam HCl in the Treatment of Elderly Patients
por: Gavin, James R., et al.
Publicado: (2014) -
Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis
por: Bodmer, Michael, et al.
Publicado: (2008) -
Weight Change in Diabetes and Glycemic and Blood Pressure Control
por: Feldstein, Adrianne C., et al.
Publicado: (2008) -
Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017) -
Dietary Behaviors Predict Glycemic Control in Youth With Type 1 Diabetes
por: Mehta, Sanjeev N., et al.
Publicado: (2008)